Clinical trials Our clinical trials M19-708 (VIALE-M) (Acute Myeloid Leukaemia - Recruitment: CLOSDED) Project Title M19-708 (VIALE-M) Official Title Randomized, Double-Blind, 2-Arm, Multicenter, Phase 3 Study of Venetoclax and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy for Patients With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy (VIALE-M) Project Summary This study will be conducted in two parts. Part 1 will be the Dose Confirmation portion to determine recommended Phase 3 dose (RPTD) of venetoclax in combination with AZA. Part 3 will be conducted in 2 phases - Dose Finding portion to determine RPTD of venetoclax in combination with CC-486 and Randomization portion to evaluate if venetoclax in combination with CC-486 as maintenance therapy improves relapse-free survival (RFS) compared to CC-486. Blood Disorder Acute Myeloid Leukaemia (AML) Patient Recruitment Details Patient recruitment status: CLOSED Number of Patients (Globally) Undetermined.